What is the CVSS score of CVE-2024-34398?

CVE-2024-34398 has a CVSS 3.1 base score of 4.2 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:N. EPSS exploitation probability: 0.1%.

Which versions of Remedy Mid Tier are affected by CVE-2024-34398?

CVE-2024-34398 presents moderate security risk rated CVSS 4.2. Exploitation could compromise the security of affected deployments.

How to fix or mitigate CVE-2024-34398?

Within 30 days: Identify affected systems and apply vendor patches as part of regular patch cycle. Monitor vendor channels for patch availability.

Remedy Mid Tier CVE-2024-34398

MEDIUM

Basic XSS (CWE-80)

2025-03-12 cve@mitre.org

XSS Remedy Mid Tier

4.2

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

4.2 MEDIUM

AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:N

Attack Vector

Network

Attack Complexity

High

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

Low

Integrity

Low

Availability

None

Lifecycle Timeline

Analysis Generated

Mar 28, 2026 - 18:31 vuln.today

CVE Published

Mar 12, 2025 - 17:15 nvd

MEDIUM 4.2

DescriptionCVE.org

An issue was discovered in BMC Remedy Mid Tier 7.6.04. The web application allows stored HTML Injection by authenticated remote attackers.

AnalysisAI

An issue was discovered in BMC Remedy Mid Tier 7.6.04. Rated medium severity (CVSS 4.2), this vulnerability is remotely exploitable. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-80. An issue was discovered in BMC Remedy Mid Tier 7.6.04. The web application allows stored HTML Injection by authenticated remote attackers. Affected products include: Bmc Remedy Mid-Tier.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.